tm logo
ALLO VIR
Live/Registered
REGISTERED

on 28 May 2024

Last Applicant/ Owned by

1100 Winter Street

Waltham

MA

02451

Serial Number

97799503 filed on 17th Feb 2023

Registration Number

7396297 registered on 28th May 2024

in the Principal Register

Correspondent Address

Maury M. Tepper, III

Maury M. Tepper, III TEPPER & EYSTER, PLLC

RALEIGH, NC 27609

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ALLO VIR

Research and development in the pharmaceutical and biotechnology fields antiviral cell therapy products in the nature of virus-specific T cells; antiviral cell therapy products for restoration and enhancement of patients' immune systems in the nature of T cells; antiviral cell therapy products for restoration and enhancement of patients' immune systems in the nature of virus-specific T cells; ant Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Research and development in the pharmaceutical and biotechnology fields


First Use Date in General

31st Oct 2023

First Use Date in Commerce

31st Oct 2023

Class [005]
Pharmaceutical Products


antiviral cell therapy products in the nature of virus-specific T cells; antiviral cell therapy products for restoration and enhancement of patients' immune systems in the nature of T cells; antiviral cell therapy products for restoration and enhancement of patients' immune systems in the nature of virus-specific T cells; antiviral allogeneic cell therapy products in the nature of T cells; antiviral allogeneic cell therapy products in the nature of virus-specific T cells; antiviral cells for medical use; antiviral T cells for medical use; antiviral virus-specific T cells for medical use; antiviral immunotherapeutic agents for restoring viral immunity in immunocompromised patients; antiviral immunotherapeutic agents, namely, T cells, for restoring viral immunity in immunocompromised patients; antiviral immunotherapeutic agents, namely, allogenic T cells, for restoring viral immunity in immunocompromised patients; antiviral immunotherapeutic agents, namely, virus-specific T cells, for restoring viral immunity in immunocompromised patients


First Use Date in General

31st Oct 2023

First Use Date in Commerce

31st Oct 2023

Mark Details


Serial Number

No 97799503

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.21 -

Circles that are totally or partially shaded

26.17.09 -

Curved line(s), band(s) or bar(s)

Legal History


Show more

Status DateAction Taken
28th May 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
28th May 2024REGISTERED-PRINCIPAL REGISTER
12th Mar 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12th Mar 2024PUBLISHED FOR OPPOSITION
21st Feb 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21st Feb 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06th Feb 2024APPROVED FOR PUB - PRINCIPAL REGISTER
09th Jan 2024EXAMINER'S AMENDMENT ENTERED
09th Jan 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09th Jan 2024EXAMINERS AMENDMENT E-MAILED